Aridis Pharmaceuticals Stock Market Value
| ARDS Stock | USD 0.0003 0 86.96% |
| Symbol | Aridis |
Aridis Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Aridis Pharmaceuticals' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Aridis Pharmaceuticals.
| 12/13/2025 |
| 01/12/2026 |
If you would invest 0.00 in Aridis Pharmaceuticals on December 13, 2025 and sell it all today you would earn a total of 0.00 from holding Aridis Pharmaceuticals or generate 0.0% return on investment in Aridis Pharmaceuticals over 30 days. Aridis Pharmaceuticals is related to or competes with HST Global. Aridis Pharmaceuticals, Inc., a late-stage biopharmaceutical company, focuses on the discovery and development of target... More
Aridis Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Aridis Pharmaceuticals' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Aridis Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 85.83 | |||
| Information Ratio | 0.3513 | |||
| Maximum Drawdown | 1091.3 | |||
| Value At Risk | (90.48) | |||
| Potential Upside | 1000.0 |
Aridis Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Aridis Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Aridis Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Aridis Pharmaceuticals historical prices to predict the future Aridis Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.2715 | |||
| Jensen Alpha | 111.27 | |||
| Total Risk Alpha | 75.43 | |||
| Sortino Ratio | 1.32 | |||
| Treynor Ratio | 5.67 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Aridis Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Aridis Pharmaceuticals Backtested Returns
Aridis Pharmaceuticals is out of control given 3 months investment horizon. Aridis Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.35, which signifies that the company had a 0.35 % return per unit of risk over the last 3 months. We were able to break down twenty-seven different technical indicators, which can help you to evaluate if expected returns of 113.02% are justified by taking the suggested risk. Use Aridis Pharmaceuticals Mean Deviation of 218.5, downside deviation of 85.83, and Risk Adjusted Performance of 0.2715 to evaluate company specific risk that cannot be diversified away. Aridis Pharmaceuticals holds a performance score of 27 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 19.95, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Aridis Pharmaceuticals will likely underperform. Use Aridis Pharmaceuticals total risk alpha and the relationship between the potential upside and price action indicator , to analyze future returns on Aridis Pharmaceuticals.
Auto-correlation | 0.22 |
Weak predictability
Aridis Pharmaceuticals has weak predictability. Overlapping area represents the amount of predictability between Aridis Pharmaceuticals time series from 13th of December 2025 to 28th of December 2025 and 28th of December 2025 to 12th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Aridis Pharmaceuticals price movement. The serial correlation of 0.22 indicates that over 22.0% of current Aridis Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.22 | |
| Spearman Rank Test | 0.99 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Aridis Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Aridis Pharmaceuticals pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Aridis Pharmaceuticals' pink sheet expected returns. We can calculate the autocorrelation of Aridis Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Aridis Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Aridis Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Aridis Pharmaceuticals pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Aridis Pharmaceuticals pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Aridis Pharmaceuticals pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Aridis Pharmaceuticals Lagged Returns
When evaluating Aridis Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Aridis Pharmaceuticals pink sheet have on its future price. Aridis Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Aridis Pharmaceuticals autocorrelation shows the relationship between Aridis Pharmaceuticals pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Aridis Pharmaceuticals.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Aridis Pink Sheet Analysis
When running Aridis Pharmaceuticals' price analysis, check to measure Aridis Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aridis Pharmaceuticals is operating at the current time. Most of Aridis Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Aridis Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aridis Pharmaceuticals' price. Additionally, you may evaluate how the addition of Aridis Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.